OSTXOS Therapies Incorporated Common Stock
1.590USD+8.90%Mkt Cap: 73.34M $P/E: —3d ago
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The com…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap73.34M $
Enterprise Value74.21M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-28.75M $
Revenue/Share—
Last Price1.590 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)4.92
PEG—
EV/EBITDA-2.00
EV/Revenue—
P/S—
P/B-9.70
EPS (TTM)-1.09
EPS (Forward)0.32
52W Range
1.15031% of range2.570
52W High2.570 USD
52W Low1.150 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE471.71%
ROA-420.41%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.24M $
CapEx (TTM)466.42K $
FCF Margin—
FCF Yield-3.52%
Net Debt-205.03K $
Net Debt/EBITDA0.01
Balance Sheet
Debt/Equity—
Current Ratio0.18
Quick Ratio0.16
Book Value/Sh-0.1640 USD
Cash/Share0.0040 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)8.918 USD
Upside (mean)+460.9%
Target Range6.000 USD – 13.00 USD
$6.000+460.9% to mean$13.00
# Analysts5
Ownership
Shares Out.46.13M
Float37.50M
Insiders21.22%
Institutions6.25%
Short Interest
Short Ratio4.0d
Short % Float6.56%
Short % Out.6.09%
Shares Short2.77M
Short (prev mo.)2.25M
Technical
SMA 501.647 (-3.4%)
SMA 2001.592 (-0.1%)
Beta—
S&P 52W Chg19.18%
Avg Vol (30d)393.86K
Avg Vol (10d)392.42K
Technical Indicators
RSI (14)50.0
MACD-0.0231
MACD Signal-0.0240
MACD Hist.+0.0009
BB Upper1.676 USD
BB Middle1.563 USD
BB Lower1.450 USD
BB Width14.41%
ATR (14)0.0949 USD
Vol Ratio (20d)1.16x